|Emory University researchers attracted $351.5 million in external research funding in fiscal year 2004, leading the state's research institutions in funding and increasing research awards by approximately 10% over fiscal year 2003. Over the past five years, from 1999 to 2004, sponsored research funding at Emory has grown by more than 71%. Federal funding was responsible for 71.8% of the total awards in FY04, and funding from the National Institutes of Health (NIH) made up 61.3% of total funding and 85.3% of Emory's federal funding.
Emory's Woodruff Health Sciences Center (WHSC) received $328.9 million, or more than 93% of the University total. Federal funding was responsible for 71.3% percent of Health Sciences Center funding, with funding from the NIH making up 62.5% percent of the WHSC total and 87.7% of WHSC's federal funding. The Health Sciences Center includes Emory University School of Medicine, the Rollins School of Public Health, the Nell Hodgson Woodruff School of Nursing, and the Yerkes National Primate Research Center.
"This is a fantastic compliment to our faculty, schools, and units, as well as our post-docs, fellows, and students," said Frank Stout, Emory vice president for research. "It is a considerable achievement during a year in which the NIH budget grew by only 3.6 percent. Emory continues to make its name and science known within the nation and the world, which means we'll continue to be able to attract additional support."
Research funding in the Rollins School of Public Health grew by 16% in FY04, and funding in the School of Medicine grew by 10%. Research funding in Emory College grew by 19% in FY04, to $20.1 million. The Department of Chemistry was the top-funded department in Emory College, with $8.4 million.
The top ten departments within the University for funded research in FY04 were the Department of Medicine (SOM); Department of Behavioral Sciences and Health Education (RSPH); Department of Psychiatry and Behavioral Sciences (SOM); Department of Pathology and Laboratory Medicine (SOM); Department of Microbiology and Immunology (SOM); Department of International Health (RSPH); Winship Cancer Institute (SOM); Department of Surgery (SOM); the Emory Vaccine Center (Yerkes and SOM); and Department of Neurology (SOM).
Cancer research projects attracted funding for Emory scientists and their collaborative partners in Georgia and throughout the region. Using $10 million in NIH grants for cancer nanotechnology, scientists at Emory and Georgia Tech are establishing a Bioengineering Research Partnership to develop nanoparticles for diagnosing and treating prostate cancer. Winship Cancer Institute (WCI) scientists are leading a consortium of 13 universities from 8 states, funded by a $10 million grant from the Department of Defense, to identify new therapeutic targets for treating advanced prostate cancer and a $7.6 million National Cancer Institute grant to uncover the pathways of prostate cancer metastasis. An Atlanta coalition of hospitals and universities led by the WCI is using a $3.7 million NIH grant to address health disparities among minorities at the new Grady Center for the Reduction of Health Disparities. Emory's Rollins School of Public Health, using $6.3 million in funding from the Centers for Disease Control and Prevention (CDC) and the support of the Georgia Cancer Coalition, has established a Cancer Prevention Research Center focused on Southwest Georgia.
Scientists at the Emory Vaccine Center received an $18 million NIH grant as part of the Integrated PreClinical/Clinical AIDS Vaccine Development Program to develop DNA-based HIV vaccines using viral vectors. A new Exploratory Center for Interdisciplinary Research in Vaccinology, part of the NIH Roadmap initiatives, combines key research centers throughout Emory and in partnership with Georgia Tech and the Institute for Systems Biology in Seattle, Washington.